Close

Articles

How FastIns Modular Cleanroom Improve Pharmaceuticals in AI Era

When it comes to the manufacturing of drugs, particularly culture of cells, a high-level of clean and sterile environment is required with temperature, humidity and differential pressure controlled to certain ranges. Typically, traditional clean rooms lack the flexibility and...

Accelerating Towards Net Zero: Transforming The Pharmaceutical Supply Chain

The pharmaceutical industry is making remarkable progress in its quest for decarbonisation, with emissions already on a significant decline. Yet, the journey to Net Zero remains fraught with challenges, particularly in curbing Scope 3 emissions within the workplace. Now...

Preparing for the revisions to the EU’s pharmaceutical legislation – what we know now

The European Parliament recently introduced compromise amendments to the revised EU pharmaceutical legislation introduced in April 2023, and they attempt to address some of the concerns of the pharmaceutical industry and, at the same time, promote innovation by small-...

How Automation Improves ADC Development

For many years, mass production has been the most prominent way to provide pharmaceuticals for all kinds of medical conditions. Large manufacturing sites have been established to produce vast amounts of uniform medications, with little room for customization. Alterations...

Pharma and Biotech’s Green Revolution

At its core the production of life-saving medicines for patients all over the world is meaningful and sustainable. Yet, there is still a considerable environmental impact in terms of waste disposal, CO2 emissions, and water/energy consumption, due to high...

Harmonizing Biologics: Navigating Immunogenicity in Drug Development

The introduction of gene therapies and therapeutic proteins has marked a revolutionary step in combating disease. However, these advanced treatments must navigate the challenging landscape of immunogenicity, where the body's defense system reacts to the introduced medication, potentially negating...

The 6-step clinical manufacturing checklist for injectable drug products

For emerging drug developers, the shift from lab to clinic is a transition that can lay the groundwork for success at many future milestones – from key early regulatory submissions to future partnerships and investment rounds. It’s an especially...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read